135 related articles for article (PubMed ID: 24850311)
1. Characterization of binding epitopes of CA125 monoclonal antibodies.
Marcos-Silva L; Narimatsu Y; Halim A; Campos D; Yang Z; Tarp MA; Pereira PJ; Mandel U; Bennett EP; Vakhrushev SY; Levery SB; David L; Clausen H
J Proteome Res; 2014 Jul; 13(7):3349-59. PubMed ID: 24850311
[TBL] [Abstract][Full Text] [Related]
2. A novel monoclonal antibody to a defined peptide epitope in MUC16.
Marcos-Silva L; Ricardo S; Chen K; Blixt O; Arigi E; Pereira D; Høgdall E; Mandel U; Bennett EP; Vakhrushev SY; David L; Clausen H
Glycobiology; 2015 Nov; 25(11):1172-82. PubMed ID: 26201951
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of carboxy-terminus specific monoclonal antibodies for understanding MUC16 cleavage in human ovarian cancer.
Aithal A; Junker WM; Kshirsagar P; Das S; Kaur S; Orzechowski C; Gautam SK; Jahan R; Sheinin YM; Lakshmanan I; Ponnusamy MP; Batra SK; Jain M
PLoS One; 2018; 13(4):e0193907. PubMed ID: 29708979
[TBL] [Abstract][Full Text] [Related]
4. Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies.
Wang CW; Hanson EK; Minkoff L; Whelan RJ
bioRxiv; 2023 Feb; ():. PubMed ID: 36798296
[TBL] [Abstract][Full Text] [Related]
5. Individual recombinant repeats of MUC16 display variable binding to CA125 antibodies.
Wang CW; Hanson EK; Minkoff L; Whelan RJ
Cancer Biomark; 2023; 37(2):85-94. PubMed ID: 37248884
[TBL] [Abstract][Full Text] [Related]
6. Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16.
Dharma Rao T; Park KJ; Smith-Jones P; Iasonos A; Linkov I; Soslow RA; Spriggs DR
Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):462-72. PubMed ID: 20453816
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker.
White B; Patterson M; Karnwal S; Brooks CL
Proteins; 2022 May; 90(5):1210-1218. PubMed ID: 35037700
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene.
Yin BW; Dnistrian A; Lloyd KO
Int J Cancer; 2002 Apr; 98(5):737-40. PubMed ID: 11920644
[TBL] [Abstract][Full Text] [Related]
9. OC125, M11 and OV197 epitopes are not uniformly distributed in the tandem-repeat region of CA125 and require the entire SEA domain.
Bressan A; Bozzo F; Maggi CA; Binaschi M
Dis Markers; 2013; 34(4):257-67. PubMed ID: 23396293
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16).
Modrak DE; Karacay H; Cardillo TM; Newsome G; Goldenberg DM; Gold DV
Int J Oncol; 2005 Jun; 26(6):1591-6. PubMed ID: 15870874
[TBL] [Abstract][Full Text] [Related]
11. Specificity and affinity of 26 monoclonal antibodies against the CA 125 antigen: first report from the ISOBM TD-1 workshop. International Society for Oncodevelopmental Biology and Medicine.
Nustad K; Bast RC; Brien TJ; Nilsson O; Seguin P; Suresh MR; Saga T; Nozawa S; Børmer OP; de Bruijn HW; Nap M; Vitali A; Gadnell M; Clark J; Shigemasa K; Karlsson B; Kreutz FT; Jette D; Sakahara H; Endo K; Paus E; Warren D; Hammarström S; Kenemans P; Hilgers J
Tumour Biol; 1996; 17(4):196-219. PubMed ID: 8685601
[TBL] [Abstract][Full Text] [Related]
12. Radiopharmacologic screening of antibodies to the unshed ectodomain of MUC16 in ovarian cancer identifies a lead candidate for clinical translation.
Nemieboka B; Sharma SK; Rao TD; Edwards KJ; Yan S; Wang P; Ragupathi A; Piersigilli A; Spriggs DR; Lewis JS
Nucl Med Biol; 2020; 86-87():9-19. PubMed ID: 32403071
[TBL] [Abstract][Full Text] [Related]
13. A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing.
Wang CW; Weaver SD; Boonpattrawong N; Schuster-Little N; Patankar M; Whelan RJ
Cancer Res Commun; 2024 Jan; 4(1):253-263. PubMed ID: 38197671
[TBL] [Abstract][Full Text] [Related]
14. Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth.
Rao TD; Fernández-Tejada A; Axelrod A; Rosales N; Yan X; Thapi S; Wang A; Park KJ; Nemieboka B; Xiang J; Lewis JS; Olvera N; Levine DA; Danishefsky SJ; Spriggs DR
ACS Chem Biol; 2017 Aug; 12(8):2085-2096. PubMed ID: 28617578
[TBL] [Abstract][Full Text] [Related]
15. Generation and characterization of a monoclonal antibody to the cytoplasmic tail of MUC16.
Gipson IK; Mandel U; Menon B; Michaud S; Tisdale A; Campos D; Clausen H
Glycobiology; 2017 Oct; 27(10):920-926. PubMed ID: 28673046
[TBL] [Abstract][Full Text] [Related]
16. Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models.
Chen Y; Clark S; Wong T; Chen Y; Chen Y; Dennis MS; Luis E; Zhong F; Bheddah S; Koeppen H; Gogineni A; Ross S; Polakis P; Mallet W
Cancer Res; 2007 May; 67(10):4924-32. PubMed ID: 17510422
[TBL] [Abstract][Full Text] [Related]
17. Dissociation in serum CA125 concentrations measured by different monoclonal antibodies.
Sakahara H; Kousaka T; Hattori N; Tomida K; Yao Z; Hosono M; Kobayashi H; Shirato M; Endo K; Konishi J
Gynecol Oncol; 1994 Mar; 52(3):301-5. PubMed ID: 7512519
[TBL] [Abstract][Full Text] [Related]
18. MUC16 is produced in tracheal surface epithelium and submucosal glands and is present in secretions from normal human airway and cultured bronchial epithelial cells.
Davies JR; Kirkham S; Svitacheva N; Thornton DJ; Carlstedt I
Int J Biochem Cell Biol; 2007; 39(10):1943-54. PubMed ID: 17604678
[TBL] [Abstract][Full Text] [Related]
19. MUC16: molecular analysis and its functional implications in benign and malignant conditions.
Haridas D; Ponnusamy MP; Chugh S; Lakshmanan I; Seshacharyulu P; Batra SK
FASEB J; 2014 Oct; 28(10):4183-99. PubMed ID: 25002120
[TBL] [Abstract][Full Text] [Related]
20. Mapping of conformational mAb epitopes to the C domain of human angiotensin I-converting enzyme.
Naperova IA; Balyasnikova IV; Schwartz DE; Watermeyer J; Sturrock ED; Kost OA; Danilov SM
J Proteome Res; 2008 Aug; 7(8):3396-411. PubMed ID: 18576678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
